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FROM PAST TO FUTURE
The World Heart Federation is the new name of the
International Society and Federation of Cardiology (ISFC),
as approved by the General Assembly that met during the
World Congress of Cardiology in Rio de Janeiro, Brazil in
April 1998. The organization was formed in 1978 by a
merger of the International Society of Cardiology (a pro-
fessional organization founded in 1946 with a world-wide
membership of national societies of cardiology), and the
International Cardiology Federation (an association of heart
foundations set up in 1970 to promote fundraising for
research, professional and public education and community
programs). The new World Heart Federation therefore has
more than 50 years’ experience of fighting heart disease
throughout the world. At present, it brings together na-
tional societies of cardiology and heart foundations from 81
countries, as well as “continental” members covering the
Asia-Pacific region, Europe, the Americas and Africa.
In recent years, the World Heart Federation has worked
in two ways: 1) through its scientific councils, which are
engaged in many projects, some of them with the World
Health Organization (WHO); 2) through its heart founda-
tions, now grouped in continental associations, which are
very active in public education relating to all aspects of heart
health. The fight against tobacco use is one important aim
of our organization. Very recently, the World Heart Fed-
eration has taken a firm position against any settlement
proposed by the United States, that does not give equal
treatment to citizens of the U.S. and citizens of other
countries. Heart foundations provide a way for laypeople—
many of them affected directly or indirectly by heart disease
and stroke—to contribute to the fight against cardiovascular
diseases, mainly by adapting the knowledge gained from
research and medical practice into health education pro-
grams for the public.
We are convinced that we now have a firm base from
which we may define the future role of the World Heart
Federation in world cardiology. We must provide leadership
and support other societies and organizations, especially our
continental and national members, in their efforts to pro-
mote cardiology world-wide. To do this we must reach a
consensus about our own aims avoiding duplication of
activities. We hope to increase even further the collabora-
tion between professional organizations and national heart
foundations within the Federation, which would benefit
both our fundraising and our scientific aims. We need to
promote joint projects with special emphasis on preventive
measures and to fight against cardiovascular (CV) diseases
in developing countries.
HEART DISEASE IN
DEVELOPING COUNTRIES: THE SECOND WAVE
According to the WHO (World Health Report 1997) (1),
circulatory disease (such as heart attacks and stroke) is
responsible for 30% of deaths throughout the world (more
than 15 million deaths per year). Cardiovascular disease,
including stroke, is the leading cause of mortality in the
U.S., accounting for more than one in three deaths in 1995
(40% of all deaths) (2). In all Western countries, ischemic
heart disease accounts for most deaths from heart disease.
This “epidemic” of heart disease is now on the decline in
developed countries, although it is still the leading cause of
death in men over 40 and women over 70 years of age. The
U.S. National Heart, Lung and Blood Institute estimates
that, in the U.S., the mortality rate from ischemic heart
disease has declined by 57% from its 1963 peak of 230 per
100,000 person/years, (3,4) and the rate of decline could be
accelerated further by means of effective education programs
to reduce the associated risk factors. However, there is no
room for complacency: For the first time since the 1960s, the
decline in cardiovascular disease mortality in the U.S. has
leveled off, and rates may actually begin to rise soon, even
though mortality from all causes has declined by 33% (5).
Most developing countries and economies in transition
are still affected by the “first wave” of heart disease—heart
disease of infective origin, especially rheumatic fever and
rheumatic heart disease and, in the Americas, Chagas’
disease. To give an example, Bangladesh has a population of
120 million, of whom 20 million are children between 5 and
15 years of age. The incidence of rheumatic fever is one case
per 1,000 children per year, or 20,000 new cases every year,
and probably more than 30% will need valvuloplasty or open
heart surgery (6). On the other hand, the prevalence of
Chagas’ disease in Latin America is approximately 20
million, and around 10% of these patients present with heart
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disease (7). In the Southern Cone countries (Argentina,
Brazil, Chile, Uruguay), the incidence of Chagas’ disease
has greatly decreased as a result of government programs to
combat transmission of the vector (8). However, the inci-
dence is still high in Andean and Central American coun-
tries, due—surprisingly—to transmission through blood
transfusions. A clear increase in new cases has been detected
in Europe, and especially in the U.S. (9).
These countries are now being overtaken by the second
wave of ischemic heart disease, due to population aging and
unhealthy eating habits and behavior, before the first wave
has passed (10–12). This is the case in Eastern Europe and
also in most countries in Africa, Asia and Latin America.
The predictions of the 1970s have thus finally come true:
Noncommunicable diseases, especially cardiovascular dis-
eases because of the considerable increase in ischemic heart
disease, have overtaken communicable diseases as the lead-
ing cause of death in every developing region of the world
except in sub-Saharan Africa and India and in economies in
transition. Even more alarming is the pessimistic prediction
for the future: According to Murray and Lopez (13), the
increase in the incidence of heart disease, especially ischemic
heart disease, will continue until 2020, mainly due to the
large increase in developing countries and economies in
transition.
There are several factors that may explain the increase in
ischaemic heart disease in developing countries. These
include: 1) increasing average lifespan; 2) decreasing infant
mortality; 3) reduced calorific intake in the early years of life;
4) an increase in gross national product and per capita
income, leading to the adoption of the unhealthy eating
habits and behaviour of western countries; 5) genetic factors
(e.g., the “thrifty gene”) (14).
THE ROLE OF THE WORLD HEART FEDERATION
Health systems in all developing countries and economies in
transition must address this growing global burden. How-
ever, they are confronted with a variety of difficulties caused
not only by local economic factors, but also by a lack of
infrastructure (both professionals and resources) for cardi-
ology and ignorance of the best way in which to proceed and
select priorities.
The WHO has been overtaken by urgent problems
related to infectious diseases, both old (malaria, cholera, and
so forth) and new (AIDS, Ebola, and so forth), and has not
studied in-depth the problem of resources and priorities for
heart disease in developing countries. We hope that, with
the appointment of Dr Gro Harlem Brundtland as the new
Director–General, positive changes will occur, although the
initial decisions taken in his field have not been promising.
With cardiovascular diseases not being included in the
present list of priorities of WHO, it is even more important
that the World Heart Federation, a truly world-wide
organization, should intensify its work. It is therefore logical
that the WHF acts as the umbrella organization for world-
wide preventive cardiology efforts (15,16). To this end, our
aim should be to increase our cooperation with developing
countries, which need our help and support most. The
countries concerned are most of those in Asia, Latin
America and Africa, as well as those of Eastern Europe,
although these are not developing countries in the strict
sense. In the fight against heart disease, the World Heart
Federation, as a world wide organization, must give partic-
ular support, at the turn of a century, to research and
prevention.
Research is necessary in all areas—epidemiological, clin-
ical and basic. It is important to gain a better understanding
of the size of the problem, current knowledge about and
future trends in risk factors, the pathophysiological mecha-
nism of cardiovascular disease, especially coronary heart
disease, and potential diagnostic and therapeutic strategies.
Activities aimed at cardiovascular disease prevention have
been instrumental in reducing mortality. For example, the
difference in the treatment of hypertension now, compared
with 50 years ago, is enormous. Reducing risk factors may
bring substantial benefits in the future. There is already
scientific evidence showing the value of controlling the most
important risk factors. A 10% decrease in blood cholesterol
brings a decrease of approximately 30% in the risk of
coronary heart disease. Using drugs to bring about a
decrease of 6 mm Hg in diastolic blood pressure of .90 mm
Hg in patients with moderate hypertension brings a 16%
decrease in coronary heart disease and a 42% decrease in
stroke. Last, giving up cigarette smoking brings a decrease
of approximately 50% in the risk of coronary heart disease
(5,17–19). The World Heart Federation therefore needs to
support the efforts of its scientific councils in their research
and prevention projects, as well as the public education and
prevention campaigns organized by its national and conti-
nental members.
We also wish to stress the importance from a clinical
point of view of nurturing the patient/physician relation-
ship, which tends to be forgotten in this era of sophisticated
“high-tech” cardiology. In our relationships with our pa-
tients, we must remember that we are dealing not only with
a medical problem, but with a person whose views, feelings
and fears must be taken into account.
Last, we must not forget a claim for solidarity. We have
to acknowledge the great differences in resources and
manpower in developed and developing countries (20). For
instance, there is one cardiologist per one million inhabit-
ants in sub-Saharan countries, and even then they do not
devote all their time to cardiology, and there is approxi-
mately one cardiac surgery team for every 50 million
inhabitants. Many small countries in this region do not even
have an echocardiograph. Even within Europe, there are
considerable differences between some developed countries
and the economies in transition of Eastern Europe. For
example, rates of coronary angioplasty and other heart
surgery per one million inhabitants may vary between
countries by a factor of more than 100. There may also be
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very striking differences between urban and rural areas
within a single country.
The aim of the World Heart Federation is to help
developing countries and economies in transition to achieve
heart health outcomes not too far removed from those
achieved in more advanced developed countries, but at a
lower cost. We must be realistic and acknowledge that it is
not feasible in these countries to implement the “high-tech”
approach that is now the norm in the U.S., most Western
European countries and some parts of the Asia-Pacific
region. Our task is to decide on measures and guidelines
that can help these countries to achieve their aims. The
success of these initiatives will depend on the support of
governments. We also need to convince WHO that one of
its priorities in the near future must be to support campaigns
to combat noncommunicable diseases.
The World Heart Federation has implemented a number
of projects devoted to the fight against heart disease partic-
ularly in developing countries, which are described briefly in
the next section.
Task forces to combat heart diseases in developing
countries: A Memorandum of Understanding has been
signed between WHO, United Nations Educational Scien-
tific and Cultural Organization (UNESCO) and the World
Heart Federation, and task forces on rheumatic fever,
Chagas’ disease and risk factors in developing countries have
been established. Her Majesty the Queen of Spain has
agreed to preside over the honorary committee for these
campaigns.
A plan of action and budget have been drawn up by the
task force on rheumatic fever. Its first action will be a
primary prevention program in Bangladesh with funding of
ECU 900,000 provided by the European Union. The task
force on risk factors in developing countries has drawn up its
plan of action and budget. Finally, various projects for the
task force on Chagas’ disease are in preparation, combined
with new plans for similar campaigns in other developing
countries.
Twin centers of cardiology. The World Heart Federation
has set up a project encouraging centers of cardiology in
developed countries to give their support to centers in
developing countries in Africa, some parts of Asia, Latin
America and the economies in transition of Eastern Europe.
The idea forms part of a global project of solidarity between
countries. The first step in this exchange is to train cardi-
ologists from developing countries. The World Heart Fed-
eration has already launched a four-year program of grants
(four grants per year), which were presented during the
1998 World Congress of Cardiology in Rio de Janeiro,
Brazil. In a second phase, we will consider the transfer of
technology and equipment, taking into account the difficulty
of maintaining equipment in such countries.
There are various potential sources of funding these
projects. In Catalonia, Spain, grants have been obtained
from the government through the funding program for
developing countries.
White Book. The World Heart Federation will publish a
White Book on cardiovascular health in developing coun-
tries and economies in transition. Similar initiatives have
recently been launched by both the Institute of Medicine
and the World Bank in the U.S. Although these projects
cover a similar area, we have tried to focus our attention on
the supply of human and other resources in the field of
cardiology throughout the world and to propose specific
measures and priorities. We hope that the White Book will
clarify the present situation of cardiovascular health care in
developing countries and economies in transition and show
the way forward, making governments and institutions
aware of the need to plan their strategies to combat heart
disease. The White Book will be presented during the
European Congress of Cardiology in Barcelona, Spain, in
August 1999.
Publications. A peer review journal, CVD prevention
(Editor-in-Chief, Darwin R. Labarthe), was launched dur-
ing the World Congress and is being published quarterly by
Futura Press. It is of value to everyone engaged in research,
practice and policy development in areas relevant to cardio-
vascular disease prevention. The quarterly bulletin of the
World Heart Federation, Hekrtbeat, is available in both
English and Spanish and is distributed to members in bulk.
It is also published on the Internet (http://www.
WorldHeart.org). The World Heart Federation encourages
Internet publications such as Timely Topics in Medicine,
produced by Prous Science (www.prous.com/ttm).
Consensus on guidelines. The number of task forces
working on cardiovascular disease risk factors worldwide is
increasing rapidly. Their conclusions may vary, owing to
socioeconomic and geographic factors, and it may be diffi-
cult to arrive at agreed guidelines to be applied throughout
the world. Three of the groups involved (the World Heart
Federation, continental societies of cardiology and conti-
nental societies dealing with hypertension and atheroscle-
rosis) are working toward such a consensus. The White
Book should provide the background information needed to
establish consensus guidelines for the diagnosis and treat-
ment of heart disease in different socioeconomic conditions,
using a cost–benefit approach.
Educational programs in cardiology. These programs
should be made available to as many countries as possible,
using new technology. Although transmission via satellite is
an attractive possibility, the easiest and least expensive
medium for developing countries is the Internet. The
World Heart Federation sponsors some of these programs
in collaboration with a number of its national and conti-
nental members. The joint program prepared with the
American College of Cardiology, which was presented at
the World Congress of Cardiology in April 1998, has been
especially important. Similar projects were carried out with
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the European Society of Cardiology during their Vienna,
Austria congress in August 1998, and with the American
Heart Association during their Scientific Sessions in Dallas
in November 1998. Future sessions could prove beneficial to
spreading educational broadcast meetings via the Internet.
Electronic information exchange. The World Heart Fed-
eration is collaborating with the American Heart Associa-
tion, the American College of Cardiology and its continen-
tal members on a World Wide Web homepage (the Global
Cardiology Network at www.globalcardiology.org) with
links to participating organizations. The discussion group
set up by the American College of Cardiology to facilitate
this work is now being administered by the European
Society of Cardiology.
A computerized catalogue facility with information on
nonresearch activities of heart foundations is held on a
database in Geneva, Switzerland. The object is to provide a
single source of information, which can be accessed via fax
or e-mail by all heart foundations.
Fundraising activities. To fund the Federation’s projects it
is necessary to work through a professional fundraising body
and to approach a wide range of public and private institu-
tions and organizations. An honorary fundraising commit-
tee has been established, presided over by Her Majesty the
Queen of Spain.
World Heart Day. The World Heart Federation has
decided to launch a yearly World Heart Day starting in the
year 2000. Preparatory work for this project is being worked
out. The theme of the day will be especially educational,
concentrated on risk factors, to be adapted to local needs by
World Heart Federation members.
CONCLUSIONS
The World Heart Federation is committed to the fight
against heart disease throughout the world. It supports
prevention and research projects organized by its councils
and members, but also conducts its own campaigns to help
developing countries appreciate the problem of cardiovas-
cular disease and find strategies to combat it. This article
aims to explain the role of World Heart Federation in this
field and to make cardiologists and others involved in heart
health aware of the problems.
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